Kinase Inhibitors in the Treatment of Myeloid Malignancies

Hematol Oncol Clin North Am. 2017 Aug;31(4):ix-x. doi: 10.1016/j.hoc.2017.05.001.

Author

Affiliation

¹ Assistant Professor of Medicine, Harvard Medical School, Division of Hematology, Brigham and Women's Hospital, Harvard Institutes of Medicine Building, Room 738, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. Electronic address: amullally@partners.org.

PMID: 28673398
DOI: 10.1016/j.hoc.2017.05.001

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Humans
Myeloproliferative Disorders / drug therapy*
Myeloproliferative Disorders / genetics
Myeloproliferative Disorders / pathology
Protein Kinase Inhibitors / therapeutic use*
Signal Transduction / drug effects
Signal Transduction / genetics

Substances

Protein Kinase Inhibitors